Transitioning from basalbolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes
Control your blood pressure with medication, diet, and exercise as directed Avoid smoking and limit alcohol, both of which harm retinal blood vessels Eat a balanced diet rich in leafy greens, fish, and colorful vegetables Stay hydrated to help your body manage fluid balance more effectively Protect your eyes from bright sunlight with quality sunglasses outdoors Manage cholesterol and triglycerides as directed Treat obstructive sleep apnea if present, and use your CPAP consistently Treatment Options When Eye Problems Develop If complications arise during semaglutide treatment, several effective interventions can preserve your vision
The clinical implication of that -arrestin-sparing profile is still under investigation, but NIH-funded research published in Nature in May 2026 found that small-molecule GLP-1 drugs access reward circuits deep within the brain circuits involved in hedonic, pleasure-driven feeding through pathways that the larger peptide molecules do not reach, suggesting the two drug classes may suppress appetite through partially distinct neural mechanisms
Convenient and Supportive Our team is dedicated to ensuring that your treatment with Wegovy is as convenient and supportive as possible
The rationale and design across its trials were described by Giblin and colleagues in Diabetes, Obesity and Metabolism in 2026 (PMID 41090431)
Full-year 2023 earnings results and 2024 financial guidance
